Cargando…
Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33
BACKGROUND: Interleukin-33 (IL-33) is an alarmin that is released following cellular damage, mechanical injury, or necrosis. It is a member of the IL-1 family and binds to a heterodimer receptor consisting of ST2 and IL-1RAP to induce the production of a wide range of cellular mediators, including t...
Autores principales: | Okragly, Angela J, Corwin, Katie Brannon, Elia, Marikka, He, Dongmei, Schroeder, Oliver, Zhang, Qing, Shiyanova, Tatiyana, Bright, Stuart, Dicker, Sarah B, Chlewicki, Lukasz, Truhlar, Stephanie M E, Davies, Julian, Patel, Chetan N, Benschop, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364917/ https://www.ncbi.nlm.nih.gov/pubmed/34408465 http://dx.doi.org/10.2147/JIR.S320287 |
Ejemplares similares
-
IL-33 released by alum is responsible for early cytokine production and has adjuvant properties
por: Rose II, William A., et al.
Publicado: (2015) -
Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies
Publicado: (1986) -
Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production
por: Rose, William A., et al.
Publicado: (2018) -
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023) -
Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
por: Peng, Sheng-Bin, et al.
Publicado: (2017)